The journey after a cancer diagnosis often involves juggling schedules, managing treatment plans and trying to glean as much information from health care providers as possible — not to mention the emotions that one must process.
Gilead Sciences, Inc. (Nasdaq: GILD) today announced a new health equity collaboration with the Satcher Health Leadership Institute (SHLI) at Morehouse School of Medicine and the Center for
Quest has expanded from our original primary focus on heart disease to a multi-pronged proactive approach that focuses on critical diagnostic insights across the cardiometabolic continuum.
The Quest Diagnostics Health Trends® series of reports are drawn from our billions of data points to provide key insights into current healthcare issues.
Following President Biden’s signature on the Inflation Reduction Act of 2022, the International WELL Building Institute (IWBI), issued the following statement from Rachel Hodgdon, IWBI President and CEO.
Illumina, a global leader in DNA sequencing and array-based technologies, announced that it will feature Dr. Karen Knudsen, CEO of the American Cancer Society, at its inaugural Illumina Genomics Forum (IGF) on October 1.
Quest Diagnostics employees volunteered for a day of service at Green Bronx Machine in New York to help students brighten up their community garden by painting murals on garden boxes filled with fresh produce grown through the program.
The insulin, manufactured and provided to Direct Relief by Lilly, was delivered to Ukraine over the past two weeks and will be allocated by Ukraine’s Ministry of Health to hospitals and clinics treating people with diabetes around the country.
The Verizon Foundation serves as an incubator for exploring how our technical and human resources can be applied in new ways to the practical concerns...
